STOCK TITAN
  1. Home
  2. Financials
  3. ADXS
  4. EPS (Diluted)

AYALA PHARMACEUTICALS INC (ADXS) EPS by Year

ADXS

AYALA PHARMACEUTICALS INC lost $7.99 per diluted share in fiscal year 2023. The table below carries 15 fiscal years, from 2009 to 2023, and the quarters AYALA PHARMACEUTICALS INC has filed alongside them.

FY2023 annual
EPS (Diluted) -$7.99
Source SEC Filings (10-K/10-Q) Latest period FY2023, ended Dec 31, 2023 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ADXS EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-KFY0910-K
EPS (Diluted)-$7.99-$13.13N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-$0.04+42.9%-$0.07N/A

ADXS EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-KQ3'2110-QQ2'2110-QQ1'2110-Q
EPS (Diluted)-$2.96-$1.53-$1.82N/A-$3.32-$3.51-$2.83N/AN/AN/AN/AN/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More AYALA PHARMACEUTICALS INC financials

Frequently Asked Questions

What was AYALA PHARMACEUTICALS INC's diluted earnings per share in fiscal year 2023?

AYALA PHARMACEUTICALS INC lost $7.99 per diluted share in fiscal year 2023.

What was AYALA PHARMACEUTICALS INC's diluted earnings per share in the most recent quarter?

AYALA PHARMACEUTICALS INC (ADXS) reported -$2.96 in diluted earnings per share in Q4 2023.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what AYALA PHARMACEUTICALS INC (ADXS) reported on that line in every period on record.